# Comparative analysis of general anaesthesia with and without dexmedetomidine in emergence agitation

## TL;DR

This study compares general anesthesia with and without dexmedetomidine to see which is better at reducing emergence agitation after maxillofacial surgery.

## Contribution

The study demonstrates that dexmedetomidine effectively reduces emergence agitation and improves recovery quality in maxillofacial surgery patients.

## Key findings

- Dexmedetomidine significantly reduced the incidence and severity of emergence agitation.
- Dexmedetomidine improved sedation scores and hemodynamic stability without increasing pain or nausea.
- Bradycardia occurred more often with dexmedetomidine but was manageable.

## Abstract

Emergence agitation (EA) is a common concern in maxillofacial surgeries under general anaesthesia. Therefore, it is of interest to
evaluate the role of intraoperative dexmedetomidine infusion in its prevention. Ninety ASA I-II adult patients were randomized into two
groups general anaesthesia alone (Group A) and general anaesthesia with dexmedetomidine (Group B). Dexmedetomidine significantly reduced
the incidence and severity of EA (p <l0.001) improved sedation scores and provided better hemodynamic stability without increasing pain,
nausea or vomiting. Bradycardia was more frequent in the dexmedetomidine group but also manageable making it a safe and effective adjuvant
for enhancing recovery quality.